Skip to main content
JAZZ logo

JAZZ · Jazz Pharmaceuticals plc · Analyst Estimates

Track JAZZ — free
$227.76 -4.59 (-1.98%) At close · Sep 30
Market Cap
$15.45B
Shares
64.91M
Volume · Sep 30 1.01M Avg daily vol (3M) 862.33K

Analyst Estimates

Compare analyst forecasts for Jazz Pharmaceuticals plc across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.

Captured 2026-09-29 10:13 UTC · Publication dates shown per estimate · 16 metric / period groups

FY ending 2026-12-31

Analyst estimates for FY ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
23.71
24.95485
26.89169
—
25.02536
25.3086
25.03266
25.38864
— — — —
EPS
analysts
Publication date not stated
— — —
17
— — — —
11
3
5
1
Revenue
USD
Publication date not stated
4624371000
4717088230
4811855960
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
20
— — — — — — — —

FY ending 2027-12-31

Analyst estimates for FY ending 2027-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
21.351
25.73857
30.97114
—
25.77113
25.72302
25.77496
25.61148
— — — —
EPS
analysts
Publication date not stated
— — —
18
— — — —
5
1
10
4
Revenue
USD
Publication date not stated
4669000000
4993777940
5265718450
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
20
— — — — — — — —

Q ending 2026-09-30

Analyst estimates for Q ending 2026-09-30
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
5.81
6.44337
7.11
—
6.46249
6.37182
6.46827
6.38676
— — — —
EPS
analysts
Publication date not stated
— — —
18
— — — —
5
1
12
1
Revenue
USD
Publication date not stated
1169846000
1205971510
1242500000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
17
— — — — — — — —

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
5.82
6.44001
8.16667
—
6.45298
6.37628
6.45189
6.43754
— — — —
EPS
analysts
Publication date not stated
— — —
17
— — — —
7
3
9
1
Revenue
USD
Publication date not stated
1182897690
1230614030
1261500000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
17
— — — — — — — —
Key facts CIK 1232524 CUSIP G50871105 13F (30d) 15 filings 13 filers Visit website Investor relations